Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001541421 | SCV001759418 | benign | not provided | 2018-06-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554421 | SCV001775666 | benign | Developmental and epileptic encephalopathy, 42 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554422 | SCV001775667 | benign | Episodic ataxia type 2 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554423 | SCV001775668 | benign | Migraine, familial hemiplegic, 1 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554424 | SCV001775669 | benign | Spinocerebellar ataxia type 6 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594332 | SCV005087278 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 94% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 87. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001541421 | SCV005314814 | benign | not provided | criteria provided, single submitter | not provided |